TOG Review (RCOG Journal)

MRCOG Part 2

Subfertility and Reproductive Medicine

WHO type 1 anovulation

Key Statistics

  • 30% — Secondary amenorrhoea due to HA
  • BMI ≥18.5 — Min. BMI before OI in HA
  • 75 IU — Starting hMG dose

Don't-miss facts

  1. HH may present overweight/obese (unlike lean/low-weight HA) – do not assume low BMI in all type 1 anovulation

  2. AMH is unreliable for ovarian reserve assessment in HH/HA (can be suppressed or falsely PCOS-like) – response to gonadotrophin stimulation is the best test

  3. HA is a diagnosis of exclusion – brain MRI indicated if headache, visual/thirst/urination change, lateralising signs, or pituitary hormone excess/deficiency features

  4. Do not use combined pill solely to restore menses/bone density in HA – masks return of ovarian function; use transdermal estrogen + cyclic progestin instead

  5. OI in HA only once BMI ≥18.5 and energy balance optimised – reduces fetal loss/SGA/preterm birth/caesarean risk

  6. hMG (not FSH alone) is preferred for type 1 anovulation OI – FSH alone in LH-deplete women gives worse follicular growth/ovulation rates

  7. Pulsatile GnRH pumps are not available for therapeutic use in the UK, despite favourable ovulation/pregnancy/multiple- pregnancy rates

  8. CBT achieved 87.5% vs 25% ovarian activity vs observation in a small HA RCT – a low-harm option to discuss

Type 1 vs PCOS at a glance

Type 1 (HH/HA/HP): FSH↓ LH↓ estradiol↓ thin endometrium, small/multicystic ovaries

PCOS: FSH normal, LH normal/high, AMH high, thick endometrium, polycystic/high-volume ovaries

Abbreviation Key

  • WHO — World Health Organization KNDy
  • neurons — kisspeptin-neurokinin B-dynorphin neurons
  • HH — hypogonadotrophic hypogonadism
  • hMG — human menopausal gonadotrophin
  • HA — hypothalamic amenorrhoea
  • IVF — in vitro fertilisation
  • HP — hypopituitarism
  • HRT — hormone replacement therapy
  • HPO axis — hypothalamo–pituitary–ovarian axis
  • CBT — cognitive behavioural therapy
  • GnRH — gonadotrophin-releasing hormone
  • DXA — dual-energy X-ray absorptiometry
  • FSH — follicle-stimulating hormone
  • OI — ovulation induction
  • LH — luteinising hormone
  • hCG — human chorionic gonadotrophin
  • AMH — anti-müllerian hormone
  • OHSS — ovarian hyperstimulation syndrome
  • PCOS — polycystic ovary syndrome

Source: Talaulikar V, Yasmin E. WHO type 1 anovulation: an update on diagnosis, management and implications for long-term health. The Obstetrician & Gynaecologist 2020;22:178–190. doi:10.1111/tog.12665

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free